1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, March 2017 (p3)

Biological Therapy Analysis & Statistics, March 2017 (p3)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

61-90 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) – Pipeline Review, ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World
Osteoarthritis - Pipeline Review, H1 2017

Osteoarthritis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis – Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia – Pipeline Review, ...

  • Industries : Therapy, Oncology
  • Countries : United States
Crigler-Najjar Syndrome - Pipeline Review, H1 2017

Crigler-Najjar Syndrome - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Crigler-Najjar Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crigler-Najjar Syndrome – Pipeline Review, H1 2017, provides ...

  • Industries : Biological Therapy
  • Countries : World, United States
Traumatic Brain Injury - Pipeline Review, H1 2017

Traumatic Brain Injury - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Traumatic Brain Injury - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury – Pipeline Review, H1 2017, provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Degenerative Disc Disease - Pipeline Review, H1 2017

Degenerative Disc Disease - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease – Pipeline Review, H1 2017, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
House Dust Mite Allergy - Pipeline Review, H1 2017

House Dust Mite Allergy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

House Dust Mite Allergy - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy – Pipeline Review, H1 2017, provides ...

  • Industries : OTC, Pharmaceutical, Chronic Disease
  • Countries : Japan, World, North America, United States, Europe
Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Hosting, Hosting, Biological Therapy, Biopharmaceutical
  • Countries : United States
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency – ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy
  • Countries : United States, World
Wounds - Pipeline Review, H2 2016

Wounds - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Wounds - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Wounds – Pipeline Review, H2 2016, provides an overview of the Wounds (Dermatology) ...

  • Industries : Medical Supply, Healthcare, Therapy, Pathology
  • Countries : United States
Androgenic Alopecia - Pipeline Review, H2 2016

Androgenic Alopecia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Androgenic Alopecia – Pipeline Review, H2 2016, provides an ...

  • Industries : OTC, Pharmaceutical
  • Countries : Japan
Global Cell Banking Market Trends, Opportunities, and Future

Global Cell Banking Market Trends, Opportunities, and Future

  • $ 1500
  • Industry report
  • January 2017
  • by Frost & Sullivan

As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding their Service Portfolio and Collaborating with Biopharmaceutical ...

  • Industries : Banking
  • Countries : World
Genethon SA - Product Pipeline Review - 2016

Genethon SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Genethon SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Genethon SA - Product Pipeline Review - 2016’, provides an overview of the Genethon SA’s pharmaceutical research and ...

  • Industries : Biological Therapy
  • Countries : World
2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 1450
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2017

Anti GM-CSF Antibody -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Anti GM-CSF Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2017

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
Growth Hormone Antagonists -Pipeline Insights, 2017

Growth Hormone Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Interleukin (IL) Inhibitors -Pipeline Insights, 2017

Interleukin (IL) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. ...

  • Industries : Biological Therapy
CD8+ T cell Activators -Pipeline Insights, 2017

CD8+ T cell Activators -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “CD8+ T cell Activators-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the CD8+ T cell Activators. The ...

  • Industries : Biological Therapy
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2017

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2017

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Broad Spectrum ...

  • Industries : Biological Therapy
Growth Hormone (GH) Agonists -Pipeline Insights, 2017

Growth Hormone (GH) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Growth Hormone (GH) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone (GH) Agonists. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.